Live Breaking News & Updates on Keytruda Biosimilar|Page 1

Stay updated with breaking news from Keytruda biosimilar. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Samsung Bioepis Initiates Phase 3 Clinical Trial for Proposed Pembrolizumab Biosimilar

The trial will compared the efficacy, safety, pharmacokinetics, and immunogenicity between SB27 and pembrolizumab for metastatic non-squamous non-small cell lung cancer. ....

Ilsun Hong , Gallaghera Samsung Bioepis , Samsung Bioepis , Keytruda Biosimilar , Keytruda Pembrolizumab , Samsung Bioepis Co Ltd , Product Evaluation Team Leader Of Samsung Bioepis , Product Evaluation Team Leader , European Union Sourced , United States Sourced , Immunogenicity Between , Bioepis Initiates Phase , Proposed Biosimilar , Proposed Keytruda ,